EMA approval process

Hi everybody,

regarding Ocrevus which we know is the marketing name for Ocrelizumab. The FDA have granted it breakthrough status and so it will be fast-tracked. Assuming they approve this drug will the EMA (Europoean authority) also grant approval automatically or will they then have to repeat the whole process, does anybody out there know?

Dave.

Sorry Dave I have no idea, but am sure someone here will have the answer.

Pam x

I heard they were fast-tracking it in the US too but not read anything concrete on the UK front yet

Sonia x